Abstract
BAT monoclonal antibody exhibited anti-tumor activity mediated by T and NK cells. We have evaluated the efficacy of murine and humanized BAT for the treatment of human colorectal carcinoma liver metastases in nude mice. HM7, a human colorectal carcinoma was injected into the spleen to colonize the liver. A single intravenous administration of both BAT antibodies significantly reduced the number of metastases and liver weights. Histological examinations demonstrated lymphocyte accumulation near remnant tumors and in tumor-free tissues of BAT treated mice. The efficacy of humanized BAT in the regression of hepatic metastases in human colorectal carcinoma has potential clinical use.
| Original language | English |
|---|---|
| Pages (from-to) | 217-222 |
| Number of pages | 6 |
| Journal | Cancer Letters |
| Volume | 229 |
| Issue number | 2 |
| DOIs | |
| State | Published - 18 Nov 2005 |
| Externally published | Yes |
Keywords
- BAT monoclonal antibody
- Cancer immunotherapy
- Liver histopathology
- Liver metastases
- Metastatic colorectal carcinoma
- Mice tumor model